Supernus Pharmaceuticals Inc (NASDAQ:SUPN)

During the Trading Day
8.00 -0.06 / -0.74%
Data as of 3:59pm ET
Day’s Change
During After-Hours   Switch to standard view »
8.00 0.00 / 0.00%
 
Volume: 11.7K
SECTOR
Health Technology
INDUSTRY
Pharmaceuticals: Other
MARKET CAP
$356.1M

Company Description

Supernus Pharmaceuticals, Inc. is a pharmaceutical company, which focuses on developing and commercializing products for the treatment of central nervous system diseases. The company has one approved product for epilepsy, Oxtellar XR and one tentatively approved product for epilepsy, Trokendi XR. It is also developing several product candidates in psychiatry to address large market opportunities in ADHD, including ADHD patients with impulsive aggression. These product candidates include SPN-810 for impulsive aggression in ADHD and SPN-812 for ADHD. The company was founded by Jack A. Khattar on December 22, 2005 and is headquartered in Rockville, MD.

Contact Information

Supernus Pharmaceuticals, Inc.
1550 East Gude Drive
Rockville Maryland 20850
P:(301) 838-2500
Investor Relations:
(301) 838-2591

Employees

Shareholders

Individual stakeholders46.04%
Mutual fund holders20.28%
Other institutional19.45%

Top Executives

Jack A. KhattarPresident, Chief Executive Officer & Founder
Gregory S. PatrickChief Financial Officer & Vice President
Padmanabh P. BhattChief Scientific Officer & Senior Vice President
Stefan K. F. SchwabeChief Medical Officer, EVP-Research & Development
Jones Woody BryanVice President-Business Development

To view my watchlist

Not a member yet?

Sign up now for a free account
Market indexes are shown in real time, except for the DJIA, which is delayed by two minutes. All times are ET. Disclaimer LIBOR Warning: Neither BBA Enterprises Limited, nor the BBA LIBOR Contributor Banks, nor Reuters, can be held liable for any irregularity or inaccuracy of BBA LIBOR. Disclaimer. Morningstar: © 2014 Morningstar, Inc. All Rights Reserved. Disclaimer The Dow Jones IndexesSM are proprietary to and distributed by Dow Jones & Company, Inc. and have been licensed for use. All content of the Dow Jones IndexesSM © 2014 is proprietary to Dow Jones & Company, Inc. Chicago Mercantile Association. The market data is the property of Chicago Mercantile Exchange Inc. and its licensors. All rights reserved. FactSet Research Systems Inc. 2014. All rights reserved. Most stock quote data provided by BATS.